Information Provided By:
Fly News Breaks for July 1, 2019
ZTS
Jul 1, 2019 | 07:37 EDT
As previously reported, BofA Merrill Lynch analyst Michael Ryskin downgraded Zoetis to Neutral from Buy, citing an "all-time high" valuation that he now views as fair following the stock's 32% year-to-date advance. After raising his estimates for a "sizeable" boost from the expected launch of Simparica Trio, Ryskin raised his price target on Zoetis shares to $120 from $111, though he sees little further upside to expectations.
News For ZTS From the Last 2 Days
There are no results for your query ZTS